In U.S. Gender Medicine, Ideology Eclipses Science. It Hurts Kids.
Imagine a comprehensive review of research on a treatment for children found “remarkably weak evidence” that it was effective.
Now imagine the medical establishment shrugged off the conclusions and continued providing the same unproven and life-altering treatment to its young patients.
This is where we are with gender medicine in the United States. It’s been three months since the release of the Cass Review, an independent assessment of gender treatment for youths commissioned by England’s National Health Service.
The four-year review of research, led by Dr. Hilary Cass, one of Britain’s top pediatricians, found no definitive proof that gender dysphoria in children or teenagers was resolved or alleviated by what advocates call gender-affirming care, in which a young person’s declared “gender identity” is affirmed and supported with social transition, puberty blockers and/or cross-sex hormones.
